LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 765 | 422 | 3101 | 0.1361 | -0.2552 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 765 | 422 | 3101 | 0.1362 | -0.2549 |
SK-BR-3 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 2543 | 739 | 5418 | 0.1364 | -0.6782 |
MCF7 | Omipalisib | 10 | uM | LJP6 | 72 | hr | 1389 | 746 | 5445 | 0.1367 | -0.2743 |
MCF 10A | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1519 | 11103 | 0.1368 | -0.0414 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1311 | 677 | 4935 | 0.1373 | -0.2930 |
MDA-MB-231 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1311 | 680 | 4935 | 0.1379 | -0.2909 |
MDA-MB-231 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 680 | 4935 | 0.1379 | -0.2907 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1389 | 760 | 5445 | 0.1389 | -0.2677 |
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 765 | 431 | 3101 | 0.1389 | -0.2475 |
MCF7 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 755 | 5445 | 0.1389 | -0.2665 |
Hs 578T | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 765 | 434 | 3101 | 0.1399 | -0.2450 |
Hs 578T | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 765 | 434 | 3101 | 0.1403 | -0.2454 |
MCF 10A | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1580 | 11217 | 0.1408 | -0.0259 |
MCF7 | AZD7762 | 10 | uM | LJP6 | 72 | hr | 1389 | 771 | 5445 | 0.1412 | -0.2608 |
BT-20 | PF431396 | 10 | uM | LJP5 | 72 | hr | 1334 | 571 | 4033 | 0.1415 | -0.4131 |
MDA-MB-231 | Canertinib | 10 | uM | LJP6 | 72 | hr | 1311 | 699 | 4935 | 0.1417 | -0.2806 |
Hs 578T | PF477736 | 10 | uM | LJP5 | 72 | hr | 765 | 446 | 3148 | 0.1419 | -0.2320 |
Hs 578T | BI-2536 | 0.04 | uM | LJP6 | 72 | hr | 765 | 440 | 3101 | 0.1420 | -0.2401 |
Hs 578T | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 765 | 447 | 3148 | 0.1421 | -0.2312 |
Hs 578T | Mitoxantrone | 1.11 | uM | LJP5 | 72 | hr | 765 | 448 | 3148 | 0.1424 | -0.2309 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1694 | 1599 | 11217 | 0.1426 | -0.0211 |
Hs 578T | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 765 | 442 | 3101 | 0.1428 | -0.2374 |
MCF7 | Buparlisib | 10 | uM | LJP5 | 72 | hr | 1389 | 844 | 5905 | 0.1430 | -0.2124 |
Hs 578T | WH-4-025 | 1.11 | uM | LJP5 | 72 | hr | 765 | 450 | 3148 | 0.1431 | -0.2298 |